Positive Developments on the HIV Front

A gene-editing protocol shows promise, and a second baby who was started on antiretroviral drugs soon after birth appears to be virus-free a year later.

By | March 7, 2014

A T cell (blue) covered in HIV (yellow)WIKIMEDIA, NIHThis week was filled with good news about treating HIV. On Thursday (March 6), researchers reported in the New England Journal of Medicine that a gene-editing method that modifies patients’ own immune cells to make some of them lack CCR5, a surface protein critical to HIV’s entry into cells, was safe to use in humans and may even reduce viral load in some HIV patients.

Extracting CD4 T cells from 12 patients, researchers from the University of Pennsylvania, the Albert Einstein College of Medicine, and Sangamo BioSciences used a zinc-finger nuclease to disable the CCR5 gene, and reinfused the immune cells—of which 11 percent to 28 percent were modified at the CCR5 gene—into the patients. HIV was at undetectable levels in one of the treated patients, and in all 6 patients who stopped their regimen of antiretroviral drugs, modified T cells declined significantly less than untreated cells. This suggested that the gene editing protected the immune cells from HIV invasion. “It’s a great strategy,” Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, who was not involved in the research, told The New York Times. “It’s exciting, interesting, elegant science. But a lot of ‘ifs’ need to be addressed before you can say ‘Wow, this could really work.’”

In other news, a nine-month-old baby in Southern California who was born with the virus appears to be HIV-free after receiving antiretroviral treatment since she was four hours old. Pediatrician Audra Deveikis gave the infant a cocktail of three drugs—AZT, 3TC, and nevirapine—at high doses typically used for treating the virus. “Of course I had worries,” Deveikis said in an interview at a Boston conference where she broke the news. “But the mother’s disease was not under control, and I had to weigh the risk of transmission against the toxicity of the meds.”

The “Long Beach baby,” as she is being called, is the second case of an HIV-positive baby becoming HIV negative after early administration of antiretrovirals. Last March, researchers reported that a baby in Mississippi was given powerful HIV medications within 30 hours of birth. That child is now three years old and is HIV free.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech